Brief: Ocuphire Presents APX3330 ZETA-1 Data At Clinical Trials At The Summit
12/06/2023 13:24
June 12 (Reuters) - Ocuphire Pharma Inc OCUP.O :
* OCUPHIRE PRESENTS APX3330 ZETA-1 DATA AT CLINICAL TRIALS
AT THE
SUMMIT (CTS) 2023
Source text for Eikon: ID:nGNX2V5b3M
Further company coverage: OCUP.O
(reuters.briefs@thomsonreuters.com)
Recent news on Opus Genetics
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Health Rounds: Experimental eye drops ease night vision problems for drivers
U.S. STOCKS ON THE MOVE-Apple, Omnicom, Jersey Mike's Subs
U.S. STOCKS ON THE MOVE-Airbnb, Lyft, Korn Ferry
Opus Genetics hits 5-year high on positive early- to mid-stage eye disease gene therapy data